← All companies
TRVI
Trevi Therapeutics, Inc.
$17.90
-0.35 -1.92%
Key statistics
from XBRL data in SEC filingsMarket cap
$2.54B
Revenue (TTM)
—
Net income (TTM)
-$45.6M
EPS (TTM)
$-0.32
P/E ratio
—
Dividend yield
—
Free cash flow
-$42.1M
Cash
$19.4M
Total assets
$180M
Gross margin
—
52-week range
$6.55 – $20.22
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Amended charter or bylaws; Shareholder vote results
Jun 4, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 5, 2026
8-K
Entered a material agreement; Results of operations (earnings release); Other events
Apr 17, 2026
10-K
Fiscal year ended 2025-12-31
Mar 17, 2026
8-K
Results of operations (earnings release)
Mar 17, 2026
8-K
Other events
Mar 9, 2026
8-K
Director or officer change
Dec 5, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
8-K
Director or officer change
Aug 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Director or officer change; Shareholder vote results
Jun 17, 2025
8-K
Entered a material agreement; Other events
Jun 4, 2025
8-K
Other events
Jun 2, 2025
8-K
Other events
Jun 2, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
10-K
Fiscal year ended 2024-12-31
Mar 18, 2025
8-K
Results of operations (earnings release)
Mar 18, 2025
8-K
Other events
Mar 10, 2025
8-K
Results of operations (earnings release); Other events
Jan 8, 2025
8-K
Entered a material agreement; Other events
Dec 16, 2024
8-K
Other events
Dec 12, 2024
8-K
Other events
Dec 3, 2024
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Results of operations (earnings release)
Nov 6, 2024
8-K
Other events
Oct 21, 2024
8-K
Other events
Oct 4, 2024
8-K
Director or officer change
Oct 1, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Shareholder vote results
Jun 13, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release)
May 7, 2024
10-K
Fiscal year ended 2023-12-31
Mar 20, 2024
8-K
Results of operations (earnings release)
Mar 20, 2024
10-Q
Quarter ended 2023-09-30
Nov 9, 2023
8-K
Results of operations (earnings release)
Nov 9, 2023